236 related articles for article (PubMed ID: 29652520)
1. Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension.
Rafikova O; Williams ER; McBride ML; Zemskova M; Srivastava A; Nair V; Desai AA; Langlais PR; Zemskov E; Simon M; Mandarino LJ; Rafikov R
Am J Respir Cell Mol Biol; 2018 Sep; 59(3):334-345. PubMed ID: 29652520
[TBL] [Abstract][Full Text] [Related]
2. Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability.
Rafikova O; James J; Eccles CA; Kurdyukov S; Niihori M; Varghese MV; Rafikov R
Biol Sex Differ; 2020 Mar; 11(1):11. PubMed ID: 32188512
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.
Irwin DC; Baek JH; Hassell K; Nuss R; Eigenberger P; Lisk C; Loomis Z; Maltzahn J; Stenmark KR; Nozik-Grayck E; Buehler PW
Free Radic Biol Med; 2015 May; 82():50-62. PubMed ID: 25656991
[TBL] [Abstract][Full Text] [Related]
4. The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
Bueno-Beti C; Hadri L; Hajjar RJ; Sassi Y
Methods Mol Biol; 2018; 1816():243-252. PubMed ID: 29987825
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?
Voelkel NF; Bogaard HJ; Al Husseini A; Farkas L; Gomez-Arroyo J; Natarajan R
Antioxid Redox Signal; 2013 May; 18(14):1810-7. PubMed ID: 22870869
[TBL] [Abstract][Full Text] [Related]
6. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
7. Endothelial-to-mesenchymal transition in pulmonary hypertension.
Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
[TBL] [Abstract][Full Text] [Related]
8. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
9. Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.
Szulcek R; Happé CM; Rol N; Fontijn RD; Dickhoff C; Hartemink KJ; Grünberg K; Tu L; Timens W; Nossent GD; Paul MA; Leyen TA; Horrevoets AJ; de Man FS; Guignabert C; Yu PB; Vonk-Noordegraaf A; van Nieuw Amerongen GP; Bogaard HJ
Am J Respir Crit Care Med; 2016 Jun; 193(12):1410-20. PubMed ID: 26760925
[TBL] [Abstract][Full Text] [Related]
10. An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease.
Redinus K; Baek JH; Yalamanoglu A; Shin HKH; Moldova R; Harral JW; Swindle D; Pak D; Ferguson SK; Nuss R; Hassell K; Nozik-Grayck E; Palmer AF; Fini MA; Karoor V; Stenmark KR; Buehler PW; Irwin DC
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391342
[TBL] [Abstract][Full Text] [Related]
11. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
[TBL] [Abstract][Full Text] [Related]
12. Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension.
Lee MH; Sanders L; Kumar R; Hernandez-Saavedra D; Yun X; Ford JA; Perez MJ; Mickael C; Gandjeva A; Koyanagi DE; Harral JW; Irwin DC; Kassa B; Eckel RH; Shimoda LA; Graham BB; Tuder RM
Am J Physiol Lung Cell Mol Physiol; 2022 Sep; 323(3):L355-L371. PubMed ID: 35763400
[TBL] [Abstract][Full Text] [Related]
13. Association between endothelial function and micro-vascular remodeling measured by synchrotron radiation pulmonary micro-angiography in pulmonary arterial hypertension.
Fuji S; Matsushita S; Hyodo K; Osaka M; Sakamoto H; Tanioka K; Miyakawa K; Kubota M; Hiramatsu Y; Tokunaga C
Gen Thorac Cardiovasc Surg; 2016 Oct; 64(10):597-603. PubMed ID: 27393332
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
Frid MG; McKeon BA; Thurman JM; Maron BA; Li M; Zhang H; Kumar S; Sullivan T; Laskowsky J; Fini MA; Hu S; Tuder RM; Gandjeva A; Wilkins MR; Rhodes CJ; Ghataorhe P; Leopold JA; Wang RS; Holers VM; Stenmark KR
Am J Respir Crit Care Med; 2020 Jan; 201(2):224-239. PubMed ID: 31545648
[No Abstract] [Full Text] [Related]
15. Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism.
Buehler PW; Baek JH; Lisk C; Connor I; Sullivan T; Kominsky D; Majka S; Stenmark KR; Nozik-Grayck E; Bonaventura J; Irwin DC
Am J Physiol Lung Cell Mol Physiol; 2012 Aug; 303(4):L312-26. PubMed ID: 22728465
[TBL] [Abstract][Full Text] [Related]
16. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.
Savai R; Pullamsetti SS; Kolbe J; Bieniek E; Voswinckel R; Fink L; Scheed A; Ritter C; Dahal BK; Vater A; Klussmann S; Ghofrani HA; Weissmann N; Klepetko W; Banat GA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2012 Nov; 186(9):897-908. PubMed ID: 22955318
[TBL] [Abstract][Full Text] [Related]
17. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
Saito T; Miyagawa K; Chen SY; Tamosiuniene R; Wang L; Sharpe O; Samayoa E; Harada D; Moonen JAJ; Cao A; Chen PI; Hennigs JK; Gu M; Li CG; Leib RD; Li D; Adams CM; Del Rosario PA; Bill M; Haddad F; Montoya JG; Robinson WH; Fantl WJ; Nolan GP; Zamanian RT; Nicolls MR; Chiu CY; Ariza ME; Rabinovitch M
Circulation; 2017 Nov; 136(20):1920-1935. PubMed ID: 28935667
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endocan attenuates monocrotaline-induced connective tissue disease related pulmonary arterial hypertension.
Zhao H; Xue Y; Guo Y; Sun Y; Liu D; Wang X
Int Immunopharmacol; 2017 Jan; 42():115-121. PubMed ID: 27912147
[TBL] [Abstract][Full Text] [Related]
20. RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats.
Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
Eur J Pharmacol; 2017 Sep; 810():83-91. PubMed ID: 28576407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
